Krónikus limfoid leukémia (CLL): vizsgálatok itt: Malajzia

1 trial · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Where

  George Town, Kota Kinabalu, Lembah Pantai

  Életkor

  18 év and over

  People

  1200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136559 · EU 2022-501697-19-01